Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?

Detalles Bibliográficos
Autores principales: Coulson-Smith, Peta, Lucassen, Anneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical Ethics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418599/
https://www.ncbi.nlm.nih.gov/pubmed/32661073
http://dx.doi.org/10.1136/medethics-2020-106106
_version_ 1783569721005703168
author Coulson-Smith, Peta
Lucassen, Anneke
author_facet Coulson-Smith, Peta
Lucassen, Anneke
author_sort Coulson-Smith, Peta
collection PubMed
description
format Online
Article
Text
id pubmed-7418599
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-74185992020-08-18 Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent? Coulson-Smith, Peta Lucassen, Anneke J Med Ethics Clinical Ethics BMJ Publishing Group 2020-08 2020-07-12 /pmc/articles/PMC7418599/ /pubmed/32661073 http://dx.doi.org/10.1136/medethics-2020-106106 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Ethics
Coulson-Smith, Peta
Lucassen, Anneke
Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
title Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
title_full Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
title_fullStr Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
title_full_unstemmed Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
title_short Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
title_sort using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
topic Clinical Ethics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418599/
https://www.ncbi.nlm.nih.gov/pubmed/32661073
http://dx.doi.org/10.1136/medethics-2020-106106
work_keys_str_mv AT coulsonsmithpeta usingbiomarkersinacutemedicinetopreventhearinglossshouldthisrequirespecificconsent
AT lucassenanneke usingbiomarkersinacutemedicinetopreventhearinglossshouldthisrequirespecificconsent

Ejemplares similares